Analyst ratings often influence investor sentiment and can drive stock prices. In this case, Longboard Pharmaceuticals has received 4 positive ratings, which could make the stock more attractive to investors and potentially drive the price up. The significant increase in the average price target also indicates a positive outlook for the stock.